Atom Investors LP Tarsus Pharmaceuticals, Inc. Transaction History
Atom Investors LP
- $1.07 Billion
- Q2 2025
A detailed history of Atom Investors LP transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Atom Investors LP holds 8,788 shares of TARS stock, worth $625,178. This represents 0.03% of its overall portfolio holdings.
Number of Shares
8,788Holding current value
$625,178% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding TARS
# of Institutions
216Shares Held
46.7MCall Options Held
7.8KPut Options Held
0-
Black Rock Inc. New York, NY3.27MShares$232 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.11MShares$221 Million1.94% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.98MShares$212 Million5.63% of portfolio
-
Jennison Associates LLC2.47MShares$176 Million0.06% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$175 Million5.96% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.9B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...